Dental products company Dentsply Sirona (NASDAQ: XRAY) will be reporting results this Tuesday after the bell. Here’s what investors should know.
Dentsply Sirona beat analysts’ revenue expectations last quarter, reporting revenues of $961 million, up 6.2% year on year. It was a softer quarter for the company, with full-year revenue guidance missing analysts’ expectations significantly and a significant miss of analysts’ full-year EPS guidance estimates.
Is Dentsply Sirona a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Dentsply Sirona’s revenue to decline 4.2% year on year, improving from the 7.8% decrease it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Dentsply Sirona has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Dentsply Sirona’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Align Technology delivered year-on-year revenue growth of 6.2%, beating analysts’ expectations by 1.8%, and Intuitive Surgical reported revenues up 23%, topping estimates by 5.8%. Align Technology traded down 1.3% following the results while Intuitive Surgical was up 7.2%.
Read our full analysis of Align Technology’s results here and Intuitive Surgical’s results here.
There has been positive sentiment among investors in the healthcare equipment and supplies segment, with share prices up 6% on average over the last month. Dentsply Sirona is up 1.5% during the same time and is heading into earnings with an average analyst price target of $14.10 (compared to the current share price of $11.81).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
